TickerFactsScreenerDevelopers

CytomX Therapeutics, Inc. (CTMX) — Revenue

Annual figures by fiscal year, from SEC filings.

2013: $888.0K2014: $5.08M2015: $7.71M2016: $15.04M2017: $71.62M2018: $59.50M2019: $26.90M2020: $68.43M2021: $37.31M2022: $53.16M2023: $101.21M2024: $138.10M2025: $76.20M$76.20M
2013Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$76.20M-44.8%
2024$138.10M+36.4%
2023$101.21M+90.4%
2022$53.16M+42.5%
2021$37.31M-45.5%
2020$68.43M+154.4%
2019$26.90M-54.8%
2018$59.50M-16.9%
2017$71.62M+376.1%
2016$15.04M+95.1%
2015$7.71M+51.9%
2014$5.08M+471.7%
2013$888.0K—